it's not clear how well they'll stack up against current migraine therapies, because head-to-head studies haven't been done. . .
. she suffered a "third brain bleed" and was pronounced brain dead on monday.
.- fremanezumab has completed phase iii trials and is under review by the fda to prevent migraine and
.